SEC Form 4 · accession 0001209191-18-032796
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Steve Gorlin
Director
Period of report
May 21, 2018
Accepted (ET)
May 23, 2018 · 9:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 21, 2018 | S | 5,557 | $3.90 | D | 418,449 | I | By spouse |
| Common StockF2 | May 22, 2018 | S | 8,546 | $3.81 | D | 409,903 | I | By spouse |
| Common Stock | holding | — | — | — | 246,280 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents closing share price on May 21, 2018.
- F2Represents closing share price on May 22, 2018.